References
Bazala V. The Historical Development of Medicine in the Croatian lands. Zagreb: Croation Publishing Bibliographic Institute; 1943. p. 9-20.
Bercovitz, J., & Feldman, M. (2006). Entrepreneurial universities and technology transfer: A conceptual framework for understanding knowledge-based economic development. Journal of Technology Transfer, 31(1), 175-188.
Bresnen, M., Edelman, L., Newell, S., Scarbrough, H., & Swan, J. (2003). Social practices and the management of knowledge in project environments. International Journal of Project Management, 21(3), 157-166.
Chen, Hua-Xing, et al. “A review of the open charm and open bottom systems.” Reports on Progress in Physics 80.7 (2017): 076201.
Chesbrough, H. W. (2003). Open Innovation: The New Imperative for Creating and Profiting from Technology. Harvard Business Press.Carayannis, E. G., & Campbell, D. F. (2009). ‘Mode 3’ and ‘Quadruple Helix’: toward a 21st-century fractal innovation ecosystem. International Journal of Technology Management, 46(3-4), 201-234.
Cuerrier, A., Turner, N. J., Gomes, T. C., Garibaldi, A., & Downing, A. (2015). Cultural Keystone Places: Conservation and Restoration in Cultural Landscapes. Journal of Ethnobiology, 35(1), 125-148.
Dai, Y., Harinantenaina, L., Brodie, P. J., & Callmander, M. W. (2017). A Review of the Genus Dioscorea: Traditional Uses and Pharmacological Research. In: G. Ramawat & J. Mérillon (Eds.), Natural Products. Springer.
De Smet PAGM, Keller K, Hansel R, Chandler RF. Adverse Effects of Herbal Drugs: Springer-Verlag. Heidelberg 1997;129(3): 137-145.
Dervendzi V. Contemporary Treatment with Medicinal Plants. Skopje: Tabernakul; 1992. p. 5-43.
Ekor, M. (2014). The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety. Frontiers in Pharmacology, 4, 177.
Ernst E, Schmidt K, Wider B. CAM research in Britain: The last 10 years. Complement Ther Clin Pract 2005;11:17-20.
European Medicines Agency. (2015). Guideline on quality of herbal medicinal products/traditional herbal medicinal products. Amsterdam: EMA.
Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000;9:105-12.
General guidelines for methodologies on research and evaluation of traditional medicine Geneva: World Health Organization; 2000 (WHO/EDM/TRM/2000.1).
Goyal M, Sasmal D, Nagori BP. Ayurveda the Ancient Science of Healing: An Insight. In: Vallisuta O, Olimat SM, editors. Drug Discovery Research in Pharmacognosy. 1st ed. Rijeka, Croatia: Tech Publication; 2012.
Immel, Stefan, and Frieder W. Lichtenthaler. “The hydrophobic topographies of amylose and its blue iodine complex.” Starch-Stärke 52.1 (2000): 1-8.
Israili AH. Humoral theory of unani tibb. Indian J Hist Sci 1981;16:95-9.
Jaiswal, Sunil Kumar, et al. “Curcumin mediated attenuation of carbofuran induced oxidative stress in rat brain.” Biochemistry Research International 2016 (2016).
Katic R. Medicine en Serbie au Moyen Age. Beograd: Scientific work; 1958. p. 7-36.
Mukherjee PW. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. New Delhi, India: Business Horizons Publishers; 2002.
Nikolovski B. Essays on the History of Health Culture in Macedonia. Skopje: Macedonian Pharmaceutical Association; 1995. p. 17-27.
Petersen, Poul Erik, and Michael A. Lennon. “Effective use of fluorides for the prevention of dental caries in the 21st century: the WHO approach.” Community dentistry and oral epidemiology 32.5 (2004): 319-321.
Pharmacopoeia of the People’s Republic of China. (2020). General Rules for Pharmaceutical Preparations in Chinese Pharmacopoeia. Beijing: China Medical Science Press.
Pieroni, A. (2008). Local plant resources in the ethnobotany of Theth, a village in the Northern Albanian Alps. Genetic Resources and Crop Evolution, 55(8), 1197-1214
Quality control methods for herbal materials. Geneva: World Health Organization; 2011
Raymond, E. S. (1999). The Cathedral and the Bazaar: Musings on Linux and Open Source by an Accidental Revolutionary. O’Reilly Media.Saxenian, A. (1994). Regional Advantage: Culture and Competition in Silicon Valley and Route 128. Harvard University Press.
Rodrigues E, Barnes J. Pharmacovigilance of herbal medicines: The potential contributions of ethnobotanical and ethnopharmacological studies. Drug Saf 2013;36:1-2.
Rogers K, editor. The 100 Most Influential Scientists of All Time. 1st ed. New York: Britannica Educational Publishing in Association with Rosen Educational Services; 2010.
Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K. M., & Latha, L. Y. (2011). Extraction, Isolation and Characterization of Bioactive Compounds from Plants’ Extracts. African Journal of Traditional, Complementary and Alternative Medicines, 8(1), 1-10.
Saul, Nicholas. Gypsies and Orientalism in German literature and anthropology of the long nineteenth century. MHRA, 2007.
Shahzad, Naiyer, et al. “Phytosterols as a natural anticancer agent: Current status and future perspective.” Biomedicine & Pharmacotherapy 88 (2017): 786-794.
Singh, Dave, et al. “Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019.” European Respiratory Journal 53.5 (2019).
Smith JE. A brief history of herbal medicine. Inspired Times 2010;4:15.
The International Pharmacopoeia, seventh edition. Geneva: World Health Organization; 2017.
U.S. Food and Drug Administration 2011. Regulatory Framework of DSHEA of 1994
U.S. Food and Drug Administration. (2004). Guidance for Industry: Botanical Drug Products.
Welsh J and McClelland M. Genomic fingerprints produced by PCR with consensus tRNA gene primers: 9Nucleic Acids Res, 1991; 19:861-866
WHO good manufacturing practices (GMP): supplementary guidelines for the manufacture of herbal medicines. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: fortieth report. Geneva: World Health Organization; 2006
WHO guidelines for selecting marker substances of herbal origin for quality control of herbal medicines. In: WHO Expert Committee on Specification for Pharmaceutical Preparations: fiftyfirst report. Geneva: World Health Organization; 2017: Annex 1 (WHO Technical Report Series, No. 1003).
WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: World Health Organization; 2003.
WHO monographs on selected medicinal plants commonly used in the Newly Independent States (NIS). Geneva: World Health Organization; 2010.
WHO monographs on selected medicinal plants, volume 1. Geneva: World Health Organization; 1999.
WHO monographs on selected medicinal plants, volume 2. Geneva: World Health Organization; 2002.
WHO monographs on selected medicinal plants, volume 3. Geneva: World Health Organization; 2007.
WHO monographs on selected medicinal plants, volume 4. Geneva: World Health Organization; 2009.
World Health Organization – Traditional Medicine Strategy
World Health Organization. (2002). Traditional Medicine Strategy 2002-2005. Geneva: World Health Organization.
World Health Organization. (2013). WHO traditional medicine strategy: 2014-2023. World Health Organization.
World Health Organization. Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. Geneva, Switzerland: World Health Organization; 2004.
Zhou J, Ouedraogo M, Qu F, Duez P. Potential genotoxicity of traditional Chinese medicinal plants and phytochemicals: An overview. Phytother Res 2013;27:1745-55.